MedTrace Logo

Eliminating Hepatitis C Virus

NCT03401697 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2021-03-24

No results posted yet for this study

Summary

Initially, HCV Informatics (C-IT) will be used to filter the EMR data of the one million people who receive care at Mount Sinai and identify candidates for HCV testing (baby boomers, patients with HIV infection) and candidates for HCV treatment (patients with positive test results for HCV RNA and no record of treatment).once treatment candidates have been identified through this proactive approach, their providers will be directly notified. HCV champions and patient navigators will be used to further lower barriers to the delivery of HCV care. They will be co-located at non-hepatology care sites and will help deliver open-label HCV treatment as part of standard medical care to 500 HIV/HCV co-infected patients and 200 patients with type 2 diabetes.

Conditions

  • Hepatitis C
  • HIV
  • Type2 Diabetes

Sponsors & Collaborators

Principal Investigators

  • Andrea D. Branch, PhD · Icahn School of Medicine at Mount Sinia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-23
Primary Completion
2021-03-01
Completion
2021-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03401697 on ClinicalTrials.gov